JP2004500321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004500321A5 JP2004500321A5 JP2000606604A JP2000606604A JP2004500321A5 JP 2004500321 A5 JP2004500321 A5 JP 2004500321A5 JP 2000606604 A JP2000606604 A JP 2000606604A JP 2000606604 A JP2000606604 A JP 2000606604A JP 2004500321 A5 JP2004500321 A5 JP 2004500321A5
- Authority
- JP
- Japan
- Prior art keywords
- reversible
- dose
- washing
- application
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000025033 vasoconstriction Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12516699P | 1999-03-19 | 1999-03-19 | |
| PCT/CA2000/000294 WO2000056743A1 (en) | 1999-03-19 | 2000-03-17 | Pharmaceutical compositions comprising metal complexes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004500321A JP2004500321A (ja) | 2004-01-08 |
| JP2004500321A5 true JP2004500321A5 (https=) | 2004-12-24 |
Family
ID=22418482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000606604A Withdrawn JP2004500321A (ja) | 1999-03-19 | 2000-03-17 | 金属錯体を含む薬学的組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20020049190A1 (https=) |
| EP (1) | EP1163247A1 (https=) |
| JP (1) | JP2004500321A (https=) |
| KR (1) | KR20010112343A (https=) |
| CN (1) | CN1391577A (https=) |
| AU (1) | AU3268500A (https=) |
| BR (1) | BR0011678A (https=) |
| CA (1) | CA2367282A1 (https=) |
| CZ (1) | CZ20013307A3 (https=) |
| HU (1) | HUP0400457A2 (https=) |
| IL (1) | IL145290A0 (https=) |
| MX (1) | MXPA01009410A (https=) |
| NO (1) | NO20014526L (https=) |
| PL (1) | PL356683A1 (https=) |
| WO (1) | WO2000056743A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1916009B (zh) | 1999-04-13 | 2010-12-15 | 阿诺麦德股份有限公司 | 制备胺铂配合物的方法 |
| JP4227701B2 (ja) * | 1999-05-25 | 2009-02-18 | 中部キレスト株式会社 | ジエチレントリアミン五酢酸ルテニウム二アンモニウム塩またはその水和物およびその製法 |
| US6489638B2 (en) * | 2000-06-23 | 2002-12-03 | Semiconductor Energy Laboratory Co., Ltd. | Light emitting device |
| US6894049B1 (en) | 2000-10-04 | 2005-05-17 | Anormed, Inc. | Platinum complexes as antitumor agents |
| US20020072512A1 (en) * | 2000-12-08 | 2002-06-13 | Metaphore Pharmaceuticals, Inc | Method of preventing and treating HIV-mediated central nervous system damage |
| GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
| NZ534912A (en) * | 2002-02-04 | 2007-08-31 | Alfama Investigacao E Desenvol | supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative |
| GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| GB2395431A (en) * | 2002-11-20 | 2004-05-26 | Northwick Park Inst For Medica | Combination of a metal carbonyl compound and a guanylate cyclase stimulant or stabilizer for the therapeutic delivery of carbon monoxide |
| US7737179B2 (en) * | 2003-08-04 | 2010-06-15 | J&J Consumer Companies, Inc. | Methods for treatment of dermatological conditions |
| AU2005210285B2 (en) | 2004-02-05 | 2008-01-24 | Kyorin Pharmaceutical Co., Ltd. | Bicycloester derivative |
| FR2873037B1 (fr) | 2004-07-13 | 2008-04-11 | Univ Pasteur | Methodes et compositions pour le traitement de cancers |
| MX2008008104A (es) * | 2005-12-21 | 2008-09-03 | Oxford Biosensors Ltd | Mediadores redox. |
| GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
| EP1995237A4 (en) | 2006-03-08 | 2011-07-06 | Kyorin Seiyaku Kk | PROCESS FOR PREPARING AN AMINOACETYLPYRROLIDINCARBONITRILE DERIVATIVE AND PRODUCTION PRODUCT THEREOF |
| ES2444695T3 (es) | 2006-06-23 | 2014-02-26 | Alethia Biotherapeutics Inc. | Polinucleótidos y polipéptidos implicados en el cáncer |
| WO2008038305A2 (en) * | 2006-09-26 | 2008-04-03 | Jegannathan Srinivas | Therapeutical formulation comprising a thiazolidinedione and a nitric oxide scavenger. |
| WO2008114857A1 (ja) | 2007-03-22 | 2008-09-25 | Kyorin Pharmaceutical Co., Ltd. | アミノアセチルピロリジンカルボニトリル誘導体の製造方法 |
| CA2740900C (en) | 2008-11-03 | 2019-09-24 | Alethia Biotherapeutics Inc. | Antibodies that specifically block the biological activity of a tumor antigen |
| DE102010014412A1 (de) | 2010-04-08 | 2012-04-19 | Friedrich-Schiller-Universität Jena | Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe |
| DE102010014411A1 (de) | 2010-04-08 | 2011-10-13 | Friedrich-Schiller-Universität Jena | Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
| SI3173427T1 (sl) | 2011-03-31 | 2019-08-30 | ADC Therapeutics SA, | Protitelesa proti antigenu 1, povezanemu z ledvicami, in antigen vezavni fragmenti le-tega |
| EP2699242B1 (en) | 2011-04-19 | 2017-11-01 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
| JP6134710B2 (ja) | 2011-07-21 | 2017-05-24 | アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． | 一酸化ルテニウム放出分子およびその使用 |
| KR102102239B1 (ko) | 2012-01-09 | 2020-04-21 | 에이디씨 테라퓨틱스 에스에이 | 유방암을 치료하기 위한 방법 |
| DE102012004132A1 (de) | 2012-02-29 | 2013-08-29 | Friedrich-Schiller-Universität Jena | Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung |
| DE102014008537A1 (de) | 2014-06-04 | 2015-12-17 | Friedrich-Schiller-Universität Jena | Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
| EP3212610B1 (en) * | 2014-10-30 | 2020-10-28 | Katholieke Universiteit Leuven | Methods for low temperature fluorine-18 radiolabeling of biomolecules |
| CN113429456B (zh) * | 2021-06-11 | 2022-05-31 | 首都医科大学 | 多肽衍生物钌类络合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5112974A (en) * | 1985-01-18 | 1992-05-12 | The Trustees Of Columbia University In The City Of New York | Mixed ligand complexes and uses thereof as binding agents to DNA |
| US4721669A (en) * | 1985-01-18 | 1988-01-26 | The Trustees Of Columbia University In The City Of New York | Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents |
| GB9317686D0 (en) * | 1993-08-25 | 1993-10-13 | Johnson Matthey Plc | Pharmaceutical compositions |
| SE9703396D0 (sv) * | 1997-09-19 | 1997-09-19 | Lincoln | Binuclear complex |
-
2000
- 2000-03-17 AU AU32685/00A patent/AU3268500A/en not_active Abandoned
- 2000-03-17 IL IL14529000A patent/IL145290A0/xx unknown
- 2000-03-17 EP EP00910468A patent/EP1163247A1/en not_active Withdrawn
- 2000-03-17 WO PCT/CA2000/000294 patent/WO2000056743A1/en not_active Ceased
- 2000-03-17 CA CA002367282A patent/CA2367282A1/en not_active Abandoned
- 2000-03-17 CZ CZ20013307A patent/CZ20013307A3/cs unknown
- 2000-03-17 KR KR1020017011819A patent/KR20010112343A/ko not_active Withdrawn
- 2000-03-17 CN CN00806748A patent/CN1391577A/zh active Pending
- 2000-03-17 BR BR0011678-5A patent/BR0011678A/pt not_active Application Discontinuation
- 2000-03-17 HU HU0400457A patent/HUP0400457A2/hu unknown
- 2000-03-17 MX MXPA01009410A patent/MXPA01009410A/es unknown
- 2000-03-17 JP JP2000606604A patent/JP2004500321A/ja not_active Withdrawn
- 2000-03-17 US US09/527,450 patent/US20020049190A1/en not_active Abandoned
- 2000-03-17 PL PL00356683A patent/PL356683A1/xx not_active Application Discontinuation
-
2001
- 2001-09-18 NO NO20014526A patent/NO20014526L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004500321A5 (https=) | ||
| JP2004502858A5 (https=) | ||
| DE50313653D1 (de) | Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel | |
| NO20030929L (no) | Guanidinobenzamider som MC4-R agonister | |
| EE05210B1 (et) | Suhkurt?vevastane preparaat ja selle kasutamine meditsiinis | |
| JP2006507281A5 (https=) | ||
| EE05169B1 (et) | Asendatud oksasolidinoonid ja nende kasutamine | |
| EE200300171A (et) | Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks | |
| EE04485B1 (et) | Kihttarindi element, selle valmistamismeetod ja kasutamine | |
| EE04452B1 (et) | Farmatseutiliselt aktiivne morfolinool ja selle kasutamine | |
| BR0017112B1 (pt) | composiÇço em bolsa solével em Água e uso da composiÇço. | |
| ID30366A (id) | Pakaian dalam sekali pakai | |
| DE60108100D1 (de) | Filmsubstrate mit innewohnenden tintenempfänglichen eigenschaften und deren herstellungsverfahren | |
| ID28997A (id) | Kedok sekali pakai, dan proses pembuatannya | |
| BRPI0405450A (pt) | Agente de revestimento | |
| DE60131663D1 (de) | Acylacetonitrile, deren herstellung und diese enthaltende miticide | |
| JP2001076484A5 (https=) | ||
| DE60014694D1 (de) | Poröser silikatischer film mit niedriger durchlässigkeit, halbleiterelement mit solchem film, und beschichtungszusammensetzung den film bildend | |
| JP2003528985A5 (https=) | ||
| DE60200719D1 (de) | Filmbildende Zusammensetzung, poröser Film und deren Herstellung | |
| JP2002022755A5 (https=) | ||
| NL1013684A1 (nl) | Verknopingsmiddel voor fotolaklaag, en fotolaklaagsamenstelling welke dezelfde omvat. | |
| DE60144265D1 (de) | Halbleiterbauelement und dessen herstelllung | |
| NO20031414D0 (no) | Ny oksabispidinforbindelse som er nyttig i behandlingen av hjertearrytmier | |
| BR0012184B1 (pt) | compostos derivados de indol, formulação farmacêutica, e, composição e uso dos compostos na fabricação de medicamentos |